TickerFactsScreenerDevelopers

LIGAND PHARMACEUTICALS INC (LGND) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2009: $522.0K2010: $70.0K2011: $78.0K2012: $595.0K2013: $377.0K2014: $6.0K2015: $93.0K2016: $1.85M2017: $2.16M2018: $887.0K2019: $2.55M2020: $4.46M2021: $8.76M2022: $17.92M2023: $3.52M2024: $1.82M2025: $452.0K$452.0K
2009Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$452.0K-75.2%
2024$1.82M-48.3%
2023$3.52M-80.4%
2022$17.92M+104.6%
2021$8.76M+96.5%
2020$4.46M+74.6%
2019$2.55M+187.8%
2018$887.0K-58.9%
2017$2.16M+16.5%
2016$1.85M+1889.2%
2015$93.0K+1450.0%
2014$6.0K-98.4%
2013$377.0K-36.6%
2012$595.0K+662.8%
2011$78.0K+11.4%
2010$70.0K-86.6%
2009$522.0K—